The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 28, 2025

Filed:

Jun. 23, 2021
Applicant:

The U.s.a., As Represented BY the Secretary, Department of Health and Human Services, Bethesda, MD (US);

Inventors:

Javed Khan, Derwood, MD (US);

Sivasubramanian Baskar, Ellicott City, MD (US);

Rimas J. Orentas, Seattle, WA (US);

Dimiter S. Dimitrov, Pittsburgh, PA (US);

Zhongyu Zhu, Frederick, MD (US);

Tai Chi Cheuk, Germantown, MD (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/46 (2006.01); A61K 39/395 (2006.01); A61K 47/68 (2017.01); A61K 47/69 (2017.01); A61P 35/00 (2006.01); C07K 16/28 (2006.01);
U.S. Cl.
CPC ...
A61K 47/6849 (2017.08); A61K 39/39558 (2013.01); A61K 47/6803 (2017.08); A61K 47/68031 (2023.08); A61K 47/6911 (2017.08); A61P 35/00 (2018.01); C07K 16/2863 (2013.01); C07K 2317/622 (2013.01); C07K 2317/77 (2013.01); C07K 2317/92 (2013.01);
Abstract

Monoclonal antibodies selected from immunized mice, immunized rabbits and a human scFv library that specifically bind fibroblast growth factor receptor 4 (FGFR4) are described. Chimeric antigen receptors, antibody-drug conjugates, immunoconjugates, bispecific antibodies and immunoliposomes comprising the disclosed FGFR4-specific antibodies are also described. The antibody compositions can be used to diagnose or treat a FGFR4-positive cancer, such as rhabdomyosarcoma, lung cancer, liver cancer, breast cancer, pancreatic cancer or prostate cancer.


Find Patent Forward Citations

Loading…